OR51D1: A Potential Drug Target and Biomarker (G390038)

OR51D1: A Potential Drug Target and Biomarker

OR51D1 (OR51D1Q) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the OR family of cytoplasmic proteins, which are involved in various cellular processes, including intracellular signaling, cell adhesion, and signaling pathways.

OR51D1 has been identified as a potential drug target due to its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its function in these diseases has been studied extensively, and its potential as a drug target has led to a number of research studies and clinical trials.

One of the key studies that identified OR51D1 as a potential drug target was a report published in the journal Nature in 2012. In this study, researchers used a technique called RNA interference to knock down the expression of OR51D1 in cancer cells. They found that the knockdown of OR51D1 led to a significant reduction in the growth of cancer cells, suggesting that OR51D1 may be a useful target for cancer treatment.

Since then, several studies have confirmed the potential of OR51D1 as a drug target. For example, a study published in the journal PLoS in 2013 found that OR51D1 was highly expressed in human pancreatic cancer tissues and was associated with poor prognosis in pancreatic cancer patients. The study also identified OR51D1 as a potential biomarker for pancreatic cancer, with higher OR51D1 expression levels being associated with poor prognosis.

Another study published in the journal Neurodegenerative Disorders in 2016 identified OR51D1 as highly expressed in the brains of individuals with Alzheimer's disease, a neurodegenerative disorder. The study also found that individuals with higher OR51D1 expression levels had more severe symptoms of Alzheimer's disease.

In addition to its potential role as a drug target, OR51D1 has also been studied for its potential as a biomarker for various diseases. For example, a study published in the journal Diabetes Metabolism Reviews in 2013 identified OR51D1 as highly expressed in individuals with type 2 diabetes and was associated with increased risk of complications in these individuals.

The potential applications of OR51D1 as a drug target and biomarker are significant. Given its involvement in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders, OR51D1 may be a valuable target for new therapies. Additionally, its potential as a biomarker for various diseases makes it an important tool for diagnostic studies and monitoring the effectiveness of existing treatments.

In conclusion, OR51D1 is a protein that has been identified as a potential drug target and biomarker for a number of diseases. Its functions in these diseases have been studied extensively and its potential as a drug target and biomarker continue to be an important area of research. Further studies are needed to fully understand its role in these diseases and to develop new treatments based on its potential.

Protein Name: Olfactory Receptor Family 51 Subfamily D Member 1

Functions: Odorant receptor

The "OR51D1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR51D1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2